Amicus Therapeutics Inc (FOLD.OQ)

FOLD.OQ on NASDAQ Stock Exchange Global Market

7.94USD
24 Dec 2014
Price Change (% chg)

$0.06 (+0.76%)
Prev Close
$7.88
Open
$7.88
Day's High
$8.07
Day's Low
$7.86
Volume
96,462
Avg. Vol
444,554
52-wk High
$8.78
52-wk Low
$1.76

FOLD.OQ

Chart for FOLD.OQ

About

Amicus Therapeutics, Inc. (Amicus) is a United States-based biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneratio... (more)

Overall

Beta: 1.72
Market Cap (Mil.): $755.77
Shares Outstanding (Mil.): 95.19
Dividend: --
Yield (%): --

Financials

  FOLD.OQ Industry Sector
P/E (TTM): -- 38.24 38.63
EPS (TTM): -0.90 -- --
ROI: -69.63 19.00 18.26
ROE: -171.84 19.75 19.13
Search Stocks

Amicus lead drug nears approval as late-stage trial succeeds

- Amicus Therapeutics Inc is a step closer to bringing its first drug to the market after trial data paved the way for its lead drug to become the first oral treatment for patients with a disorder that causes an abnormal build-up of fat.

20 Aug 2014

UPDATE 3-Amicus lead drug nears approval as late-stage trial succeeds

* Migalastat as effective as standard therapies for Fabry disease

20 Aug 2014

Amicus's fat accumulation drug effective in second late-stage study

Aug 20 - Amicus Therapeutics Inc said its experimental drug was as effective as enzyme replacement therapies (ERTs) after 18 months in patients with an inherited disorder that leads to the abnormal build-up of fat.

20 Aug 2014

Competitors

  Price Change
Sanofi SA (SASY.PA) €74.99 -0.65
Shire PLC (SHP.L) 4,470.00p -63.00
Shire PLC (3159084.L) -- --
Actelion Ltd (ATLN.VX) CHF116.60 -2.00
Protalix BioTherapeutics Inc. (PLX.TA) 710.00₪ -10.10

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks